162 related articles for article (PubMed ID: 35381466)
1. Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: In vitro and in silico analysis.
Fawzi M; Oubella A; Bimoussa A; Bamou FZ; Khdar ZA; Auhmani A; Riahi A; Robert A; Morjani H; Itto MYA
Comput Biol Chem; 2022 Jun; 98():107666. PubMed ID: 35381466
[TBL] [Abstract][Full Text] [Related]
2. Novel isoxazoline-linked 1,3,4-thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation.
Oubella A; Byadi S; Bimoussa A; Fawzi M; Auhmani A; Podlipnik C; Morjani H; Riahi A; Robert A; Itto MYA
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200066. PubMed ID: 35594031
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies.
Oubella A; Bimoussa A; Byadi S; Laamari Y; Fawzi M; N'ait Ousidi A; Oblak D; Auhmani A; Riahi A; Morjani H; Ait Itto MY
J Biomol Struct Dyn; 2023 Mar; 41(5):1930-1943. PubMed ID: 35014592
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells.
Nafie MS; Amer AM; Mohamed AK; Tantawy ES
Bioorg Med Chem; 2020 Dec; 28(24):115828. PubMed ID: 33166925
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
[TBL] [Abstract][Full Text] [Related]
6. Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1,2,3-triazole-isoxazoline hybrids using the eugenol as a precursors.
Oubella A; Taia A; Byadi S; Ait Lahcen M; Bimoussa A; Essaber M; Podlipnik C; Morjani H; Ait Itto MY; Aatif A
J Biomol Struct Dyn; 2023 Apr; 41(7):2759-2771. PubMed ID: 35174765
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
[TBL] [Abstract][Full Text] [Related]
8. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
10. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
11. New 1,3,4-thiadiazoles derivatives: synthesis, antiproliferative activity, molecular docking and molecular dynamics.
Bimoussa A; Oubella A; Bamou FZ; Khdar ZA; Fawzi M; Laamari Y; Ait Itto MY; Morjani H; Auhmani A
Future Med Chem; 2022 Jun; 14(12):881-897. PubMed ID: 35670219
[No Abstract] [Full Text] [Related]
12. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Molecular Docking, and Biological Studies of New Heterocyclic Compounds Derived from β-Diketones as Novel EGFR and Pim-1 Inhibitors Endowed with AntitumorActivity.
Mohareb RM; Bagato NMA; Radwan IT
Anticancer Agents Med Chem; 2022; 22(14):2558-2576. PubMed ID: 35023461
[TBL] [Abstract][Full Text] [Related]
15. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities.
Abouzid KAM; Al-Ansary GH; El-Naggar AM
Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341
[TBL] [Abstract][Full Text] [Related]
16. Activation of Intrinsic Apoptosis and G1 Cell Cycle Arrest by a Triazole Precursor, N-(4-chlorophenyl)-2-(4-(3,4,5-trimethoxybenzyloxy)benzoyl)-hydrazinecarbothioamide in Breast Cancer Cell Line.
Arulnathan SB; Leong KH; Ariffin A; Kareem HS; Cheah KKH
Anticancer Agents Med Chem; 2020; 20(9):1072-1086. PubMed ID: 32188392
[TBL] [Abstract][Full Text] [Related]
17. Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition.
Aboukhatwa SM; Ibrahim AO; Aoyama H; Al-Behery AS; Shaldam MA; El-Ashmawy G; Tawfik HO
Bioorg Chem; 2022 Dec; 129():106126. PubMed ID: 36108589
[TBL] [Abstract][Full Text] [Related]
18. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
19. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]